Nosocomial ventriculitis and meningitis in neurocritical care patients

BackgroundExternal ventricular drainage (EVD) is frequently necessary in neurological and neurosurgical intensive care patients. A major complication of this procedure is an EVD-related venticulitis or meningitis. The purpose of this review is (1) to address the magnitude of the problem in the neurocritical care patient population, (2) to discuss the difficulties in providing an appropriate and timely diagnosis of this disease entity and (3) to propose an algorithm for both rapid diagnosis and appropriate therapy.MethodsA MEDLINE literature search was carried out for studies from January 1990 through March 2008 reporting on ventriculostomy, EVD-related central nervous system infections, in particular ventriculitis and meningitis.ResultsEVD-related ventriculitis is a serious nosocomial complication in the neurocritical care setting where EVD catheters are frequently used for the management of elevated ICP secondary to acute hydrocephalus primarily caused by subarachnoid and intraventricular hemorrhage or traumatic brain injury. Infection rate is high with reported incidences in the range of 5 % up to more than 20 %. Predisposing factors for infection are non-adherence to rigid insertion and maintenance protocols, leakage of cerebrospinal fluid (CSF), catheter irrigation and the frequency of EVD manipulation. Diagnosis is frequently impaired either by the presence of systemic inflammation due to the primary disease or because the hemorrhagic CSF itself may cause an inflammatory reaction. Furthermore, the most common pathogens involved in EVD-related infections, i. e., staphylococci, initially provoke only a mild inflammatory response in the CSF and therefore patients rarely present with clear-cut clinical signs indicating severe central nervous system infection, in particular, ventriculitis.ConclusionNosocomial EVD-related ventriculitis is a significant cause of morbidity and mortality in critically ill neurological patients. Rapid diagnosis and prompt initiation of appropriate antimicrobial therapy is needed. A stepwise algorithm for the management of EVD-related ventriculitis is proposed.

[1]  G Sherman,et al.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.

[2]  R. Narayan,et al.  Ventriculostomy-Related Infections , 1984 .

[3]  W. Ziai,et al.  Advances in the management of central nervous system infections in the ICU. , 2006, Critical care clinics.

[4]  E. Connolly,et al.  Ventriculostomy-related Infections: A Critical Review of the Literature , 2002, Neurosurgery.

[5]  S. Black.  Impact of Nosocomial Infectious Complications after Subarachnoid Hemorrhage , 2009 .

[6]  M. Williams,et al.  Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  E. Kuijper,et al.  Bacterial meningitis caused by the use of ventricular or lumbar cerebrospinal fluid catheters. , 2005, Journal of neurosurgery.

[8]  M. Falagas,et al.  Linezolid for the Treatment of Patients with Central Nervous System Infection , 2007, The Annals of pharmacotherapy.

[9]  U. Bogdahn,et al.  Continuous-pressure controlled, external ventricular drainage for treatment of acute hydrocephalus--evaluation of risk factors. , 1992, Neurosurgery.

[10]  W. Gormley.  External ventricular drain infections are independent of drain duration: an argument against elective revision , 2008 .

[11]  R. Danesi,et al.  Linezolid Cerebrospinal Fluid Concentration in Central Nervous System Infection , 2007, Journal of chemotherapy.

[12]  J. Olson,et al.  Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. , 2003, Journal of neurosurgery.

[13]  Cheng-Hsien Lu,et al.  Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors , 2002, Clinical Neurology and Neurosurgery.

[14]  P. Linden.  Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem. , 2007, Drug safety.

[15]  Marin H Kollef,et al.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. , 2002, Chest.

[16]  T. Czech,et al.  Early diagnosis of external ventricular drainage infection: results of a prospective study , 2003, Journal of neurology, neurosurgery, and psychiatry.

[17]  N. Gantz,et al.  Intracranial pressure monitors. Epidemiologic study of risk factors and infections. , 1986, The American journal of medicine.

[18]  R. Geskus,et al.  Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis. , 2006, Journal of neurosurgery.

[19]  M. Anagnostaki,et al.  Serum and Cerebrospinal Fluid Concentrations of Linezolid in Neurosurgical Patients , 2006, Antimicrobial Agents and Chemotherapy.

[20]  L. Puybasset,et al.  Prevention of external ventricular drain – related ventriculitis , 2004, Acta Neurochirurgica.

[21]  Eric Simrod.  Intracranial pressure monitors. Epidemiologic study of risk factors and infections:Aucoin PJ, Kotilainen HR, Gantz NM, et al Am J Med 80:369–376 Mar 1986 , 1986 .

[22]  R. Beer,et al.  Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. , 2003, Journal of neurosurgery.

[23]  M. Buchfelder,et al.  Serum procalcitonin monitoring for differential diagnosis of ventriculitis in adult intensive care patients , 2002, Intensive Care Medicine.

[24]  W. A. Kelly,et al.  Use of antibiotics with external ventriculostomies. , 1972, Journal of neurosurgery.

[25]  A. Upton,et al.  Clinical parameters do not predict infection in patients with external ventricular drains: a retrospective observational study of daily cerebrospinal fluid analysis. , 2008, Journal of medical microbiology.

[26]  K. Moore,et al.  Bacterial Ventriculitis and Duration of Ventriculostomy Catheter Insertion , 1993, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[27]  R. Helbok,et al.  Pharmacokinetics of Intravenous Linezolid in Cerebrospinal Fluid and Plasma in Neurointensive Care Patients with Staphylococcal Ventriculitis Associated with External Ventricular Drains , 2006, Antimicrobial Agents and Chemotherapy.

[28]  H. Rüden,et al.  Surveillance of nosocomial infections in a neurology intensive care unit , 2001, Journal of Neurology.

[29]  L. Mermel,et al.  Guidelines for the management of intravascular catheter-related infections. , 2001, Infection control and hospital epidemiology.

[30]  C. Avezaat,et al.  Risk factors for infections related to external ventricular drainage , 2008, Acta Neurochirurgica.

[31]  G. Kemmler,et al.  Cell index – a new parameter for the early diagnosis of ventriculostomy (external ventricular drainage)-related ventriculitis in patients with intraventricular hemorrhage? , 2004, Acta Neurochirurgica.

[32]  C. Inderlied,et al.  Imipenem/cilastatin treatment of bacterial meningitis in children , 1991, The Pediatric infectious disease journal.

[33]  K. Holloway,et al.  Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. , 1996, Journal of neurosurgery.

[34]  E. Brown,et al.  Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin. , 2007, The Journal of antimicrobial chemotherapy.

[35]  D. Maki,et al.  Intravascular catheter-related infections: advances in diagnosis, prevention, and management. , 2007, The Lancet. Infectious diseases.

[36]  A. Obwegeser,et al.  Efficacy of Silver Nanoparticles-Impregnated External Ventricular Drain Catheters in Patients with Acute Occlusive Hydrocephalus , 2008, Neurocritical care.

[37]  L. Briceland,et al.  Intrathecal Administration of Amikacin for Treatment of Meningitis Secondary to Cephalosporin-Resistant Escherichia Coli , 1993, The Annals of pharmacotherapy.

[38]  Ben Wong,et al.  Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? , 2004, The Journal of antimicrobial chemotherapy.

[39]  Hanan H Balkhy,et al.  Ventriculostomy-associated infections: incidence and risk factors. , 2005, American journal of infection control.

[40]  J. Bartlett.  Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia , 2004 .

[41]  J. Tarrand,et al.  Central Venous Catheter–Related Bacteremia Due to Gram-Negative Bacilli: Significance of Catheter Removal in Preventing Relapse , 2004, Infection Control & Hospital Epidemiology.

[42]  M. Zeitlinger,et al.  Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. , 2004, The Journal of antimicrobial chemotherapy.

[43]  R. Salomão,et al.  Risk Factors for Death in Patients With Candidemia , 1998, Infection Control & Hospital Epidemiology.

[44]  S. Schwab,et al.  Serum procalcitonin in cerebral ventriculitis , 2002, Critical care medicine.

[45]  R. Narayan,et al.  Ventriculostomy-related infections. A prospective epidemiologic study. , 1984, The New England journal of medicine.